Tizanidine Tablet
Product Images NDC 68788-8741

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 68788-8741). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1.jpg (Figure 1)

Figure-1.jpg (Figure 1)
A line graph displaying mean plasma tizanidine concentration (ng/mL) over time (hours) up to 25 hours after dosing. It compares profiles for 2 x 4 mg tizanidine tablets and capsules under fasted and fed conditions, with four distinct lines representing each condition.*
FDA Label Image

Figure-2.jpg (Figure 2)

Figure-2.jpg (Figure 2)
Line graph depicting mean change in muscle tone from baseline over 6 hours post-dose, measured by the Ashworth Scale. It compares 16 mg and 8 mg doses of tizanidine and placebo, showing improvement trends and confidence intervals for each group.*
FDA Label Image

Figure-3.jpg (Figure 3)

Figure-3.jpg (Figure 3)
A line graph titled 'Seven Week Study—Mean Change in Muscle Tone 0.5 to 2.5 Hours After Dosing as Measured by the Ashworth Scale ± 95% Confidence Interval.' The Y-axis represents 'Improvement in Ashworth Score,' with negative values indicating improvement. The X-axis shows time points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). Two data series are plotted: tizanidine (mean dose 28.8 mg) and placebo, showing mean changes with confidence intervals at each time point.*
FDA Label Image

Chemical-structure (Tizanidine Imtb 01)

Chemical-structure (Tizanidine Imtb 01)
Chemical structure of tizanidine hydrochloride, showing its molecular framework with chlorine, nitrogen, sulfur atoms, and associated bonds as depicted in the image.*
FDA Label Image

Tizanidine Hydrochloride Tablet 4mg (Tizanidine Label 4mg 150s)

Tizanidine Hydrochloride Tablet 4mg (Tizanidine Label 4mg 150s)
Label for Tizanidine Hydrochloride Tablet 4 mg, generic for Zanaflex, manufactured by Apotex Inc. The label includes storage instructions, warnings about drowsiness, and notes the tablet is round, white, quartered, and imprinted with APO TI-4. The label also features a barcode, a QR code, and bilingual dosage directions in English and Spanish.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.